Patients who took a GLP-1 drug fared better than those in a control group at keeping their blood glucose levels in a healthy ...

Regeneron is hoping a new program will widen patient access to its eye drug without also benefiting the company's rivals — a ...

The decision by Health and Human Services Secretary Robert F. Kennedy Jr. to remove and replace all members of the government ...

WASHINGTON — A key Senate health leader is calling for this week’s meeting of the panel of vaccine advisers handpicked by ...

This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and ...

A polymer-based device cleared by the FDA offers physicians a new way for repairing peripheral nerve injuries.

She wrote that she decided to leave the agency after taking a recent vacation, and thanked staff for their “unwavering ...

Researchers have estimated Medicaid cuts could result in more than 16,600 preventable deaths a year. But they also say that’s ...

In one of the most substantial deals of the year so far, Abridge on Tuesday announced it raised a $300 million Series E ...

Good morning! Today, we get deeper into the ousting of Nicole Verdun at the FDA, see promise from Vertex’s cell therapy for ...

Nektar Therapeutics said its embattled immune drug rezpeg significantly improved skin clearance rates in patients with atopic ...

The U.S. may be headed for a “choose your own adventure” approach to vaccine policy, in which skeptical parents follow the ...